Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats

Hypertension

Volumn 29, Issue 3, 1997, Pages 728-735

  Yagi, Keiko ^a   Kim, Shokei ^a   Wanibuchi, Hideki ^a   Yamashita, Tatsuya ^b   Yamamura, Yoshitaka ^b   Iwao, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

blood pressure; diabetes mellitus; heart; nephropathy, diabetic; transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COMPLEMENTARY DNA; LAMININ; MESSENGER RNA; MYOSIN HEAVY CHAIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEINURIA;

EID: 0031025367     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.3.728     Document Type: Article

References (47)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390-1398.
2. Garcia ML, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes. 1974;23:105-111.
3. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 1989;84:1693-1700.
4. Parker TG, Schneider MD. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol. 1991;53: 179-200.
5. Schwartz K, Carrier L, Mercadier JJ, Lompre AM, Boheler KR. Molecular phenotype of the hypertrophied and failing myocardium. Circulation. 1993;87(suppl VII):VII-5-VII-10.
6. Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B. Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts. Circ Res. 1991;69:483-490.
7. Chapman D, Weber KT, Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res. 1990; 67:787-794.
8. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium, fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
9. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther. 1994;273:509-515.
10. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422-1428.
11. MacKay K, Kondaiah P, Danielpour D, Austin HA, Brown PD. Expression of transforming growth factor-β1 and β2 in rat glomeruli. Kidney Int. 1990;38:1095-1100.
12. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int. 1994;46:1346-1358.
13. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995;25:1252-1259.
14. Mahdavi V, Chambers AP, Nadal-Ginard B. Cardiac α- and β-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci U S A. 1984;81:2626-2630.
15. Shani M, Nudel U, Zevin-Sonkin D, Zakut R, Givol D, Katcoff D, Carmon Y, Reiter J, Frischauf AM, Yaffe D. Skeletal muscle actin mRNA: characterization of the 3′ untranslated region. Nucleic Acid Res. 1981;9:579-589.
16. Mayer Y, Czosnek H, Zeelon PE, Yaffé D, Nudel U. Expression of the genes coding for the skeletal muscle and cardiac actins in the heart. Nucleic Acids Res. 1984;12:1087-1100.
17. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acid Res. 1990;18:3059.
18. Genovese C, Rowe D, Kream B. Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry. 1984;23:6210-6216.
19. Liau G, Yamada Y, de-Crombrugghe BD. Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem. 1985;260:531-536.
20. Oberbaumer I, Laurent M, Schwarz U, Sakurai Y, Yamada Y, Vogeli G, Voss T, Siebold B, Glanville RW, Kuhn K. Amino acid sequence of the non-collagenous globular domain (NC1) of the α1(IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem. 1985;147:217-224.
21. Sasaki M, Yamada Y. The laminin B2 chain has a multidomain structure homologous to the B1 chain. J Biol Chem. 1987;262: 17111-17117.
22. 2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature. 1985;316:696-700.
23. Fort P, Marty L, Piechaczyk M, el-Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
24. 1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension. 1995;26:119-207.
25. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992;41:297-309.
26. Kim S, Tokuyama M, Hosoi M, Yamamoto K. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats. Hypertension. 1992;20:280-291.
27. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA. 1974;229:1749-1754.
28. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60:885-899.
29. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J. 1989; 118:1000-1012.
30. Regan TJ, Ettinger PO, Khan MI, Jesrani MY, Lyons MM, Oldewurtel HA, Weber M. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res. 1974;35:222-237.
31. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat: changes in active and passive properties of the left ventricle. J Clin Invest. 1990;86:481-488.
32. Feuvray D, Idell-Wenger JA, Neely JR. Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res. 1979; 44:322-329.
33. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: chicken, egg, or neither? Diabetologia. 1984; 26:99-102.
34. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular diseases: putative association via common antecedents: further evidence from the Whitehall Study. Diabetolosia. 1988;31:737-740.
35. Stern MP. Diabetes and cardiovascular diseases: the 'common soil' hypothesis. Diabetes. 1995;44:369-374.
36. Hewett TE, Grupp IL, Grupp G, Robbins J. α-Skeletal actin is associated with increased contractility in the mouse heart. Circ Res. 1994;74:740-746.
37. Dillmann WH. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes. 1980;29:579-582.
38. The National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension. 1994;23: 145-158.
39. Epstein M, Sowers J. Diabetes mellitus and hypertension. Hypertension. 1992;19:403-418.
40. Ohta K, Kim S, Iwao H. Role of angiotensin-converting enzyme, adrenergic receptors and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension. 1996;28:627-634.
41. Ohta K, Kim S, Hamaguchi A, Miura K, Yukimura T, Iwao H. Cardiac hypertrophy-related gene expression in spontaneously hypertensive rats: crucial role of angiotensin AT1 receptor. Jpn J Pharmacol. 1995;67:95-99.
42. Van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease Circulation. 1990;82:848-855.
43. Border WA, Ruoslahti E. Transforming growth factor-β1 in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
44. Ohta K, Kim S, Hamaguchi A, Yukimura T, Miura K, Takaori K, Iwao H. Role of angiotensin II in extracellular matrix and transforming growth factor-β1 in hypertensive rats. Eur J Pharmacol. 1994; 269:115-119.
45. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature. 1990;346:371-374.
46. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A. 1993; 90:1814-1818.
47. Shankland SJ, Scholey JW. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int. 1994;46:430-442.